ClinicalTrials.gg
Status unknownNCT04335916Updated Apr 7, 2020

Survey on Pre-ECT Evaluation and ECT Application

An observational study in Depression, Catatonia and Schizophrenia, sponsored by Klinički Bolnički Centar Zagreb. Status unknown at 1 site in Croatia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-07.

Sponsored by Klinički Bolnički Centar Zagreb · Observational

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to identify specifics of pre-ECT assessments and ECT application in European psychiatric services. We will engage European centres that provide ECT for psychiatric patients and for psychiatric indications. It could bring better insights on current standards and possibly give some further improvements in the field of European ECT practices.

Read the detailed description

Electroconvulsive therapy (ECT) is an extremely important therapeutic method in the treatment of certain psychiatric conditions. Its' effect has been demonstrated in many clinical trials, and the indications for the use of ECT are clearly defined. Thus, the absolute indications for the use of ECT are catatonia and malignant neuroleptic syndrome, while the relative indications for ECT are therapy-resistant schizophrenia, depression and chronic suicidality. When the lead psychiatrist sets an indication for the use of ECT, pre-ECT evaluation is conducted. Although the pre-evaluation aims to assess the psychophysical condition of the patient and to determine the potential risks and possible side effects of such therapy, no clear algorithm of procedures is specified. There is no data on clear guidelines for the necessary processing prior to the application of ECT, both at national levels and globally. The assessment recommendations, however, are very broad, and most of them are focused on the ethical issues of applying ECT. The standardized pre-ECT evaluation would provide physicians and patients a systematic and evidence-based risk assessment and presumption of adverse reaction profiles.

02

Conditions studied

  • Depression
  • Catatonia
  • Schizophrenia
  • Schizoaffective Disorder
  • Suicidal Intention
  • Malignant Neuroleptic

Keywords

  • Electroconvulsive therapy
  • Pre-ECT evaluation
03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 30 is below the median of 175 across 1,257 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Klinički Bolnički Centar Zagreb is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Departments that provide pre-ECT assessment, ECT application or both in Europe

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • departments that provide pre-ECT assessment
  • departments that provide ECT application
  • departments that provide both pre-ECT assessment and ECT application

Exclusion criteria

Exclusion Criteria:

  • departments that used to provide either pre-ECT assessment or ECT application
  • departments that refer patients for ECT but don't provide pre-ECT assessment
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. pre-ECT evaluation data

    Data on pre-ECT evaluation collected with specially designed survey for this research. Pre-ECT evaluation treatment includes are there written or agreed indications, inclusion and exclusion criteria and pre-ECT evaluation, the common neuropsychiatric and somatic evaluation for ECT candidate.

    Time frame: Baseline

  2. ECT administration data

    Data on ECT application collected with specially designed survey for this research. The survey examines the most common methods of applying ECT, provided education and the necessary legal and ethical codes.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Klinički Bolnički Centar Zagreb
    Zagreb, City Of Zagreb 10000, Croatia
    Recruiting
08

References and documents

Publications

  • Medved S, Zaja N, Gazdag G, Lengvenyte A, Morkl S, Mucci F, Ristic I, Jerotic S, Regente JF, Ivanovic I, Purisic A, Sasvary F, Sivasanker V, Ziblak A, Lookene M, Sienaert P, Szczegielniak A, Trancik P, Becirovic E, Koutsomitros T, Grech G, Tapoi C, Radmanovic B, Strohle A, Bajs Janovic M, Sartorius N. Preliminary Assessment of Pre-Electroconvulsive Therapy Evaluation Practices in European Countries: The Need for Guidelines. J ECT. 2022 Dec 1;38(4):230-237. doi: 10.1097/YCT.0000000000000854. Epub 2022 Apr 23. PubMed 35462388 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04335916
Lead sponsor
Klinički Bolnički Centar Zagreb
Responsible party
Sponsor
First posted
Apr 7, 2020
Start date
Apr 1, 2020 (estimated)
Primary completion
Sep 1, 2020 (estimated)
Completion
Nov 1, 2020 (estimated)
Last update
Apr 7, 2020

Study contacts

Sara Medved
Contact
smedved@kbc-zagreb.hr
+38512388888

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion